Nicolas W. Wieder
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry study.
Journal: PloS one
Published: August 24, 2026
Transferability of a US claims-based machine learning model for ATTRwt-CM identification: a retrospective evaluation in a German setting.
Journal: Scientific reports
Published: March 05, 2026
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteria.
Journal: Neurological research and practice
Published: July 16, 2025
On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry study.
Journal: PloS one
Published: July 08, 2025
FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity.
Journal: bioRxiv : the preprint server for biology
Published: March 03, 2023
Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.
Journal: The Journal of clinical investigation
Published: June 15, 2020
Simulation Strategies for Calcium Microdomains and Calcium Noise.
Journal: Advances in experimental medicine and biology
Published: October 25, 2019
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy.
Journal: Cell
Published: August 06, 2018
Lysine trimethylation regulates 78-kDa glucose-regulated protein proteostasis during endoplasmic reticulum stress.
Journal: The Journal of biological chemistry
Published: May 16, 2017
GDC-0879, a BRAFV600E Inhibitor, Protects Kidney Podocytes from Death.
Journal: Cell chemical biology
Published: April 27, 2017
Last Updated: 09/26/2026